GlaxoSmithKline: Mepolizumab recommended for approval in Europe

NEUTRAL, Fair Value 1520p vs. 1470p (+21%)

News published on September Friday 25, 2015

Share on

For more information, please contact marketing@bryangarnier.com

The Essentials

Everything you need to know about investment banking dedicated to growth

Recent Transactions Highlights

From M&A, to IPOs see what’s been happening at Bryan, Garnier & Co this year

Join our Team

Bryan, Garnier & Co is always looking for talent in all our divisions, at all levels